SEARCH

SEARCH BY CITATION

References

  • Armogida M., Petit A., Vincent B., Scarzello S., Da Costa C. A. and Checler F. (2001) Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts. Nat. Cell Biol. 3, 10301033.DOI: 10.1038/ncb1101-1030
  • Arnold S. E., Hyman B. T., Flory J., Damasio A. R. and Van Hoesen G. W. (1991) The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103116.
  • Bahr B. A., Hoffman K. B., Yang A. J., Hess U.S., Glabe C. G. and Lynch G. (1998) Amyloid beta protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor protein. J. Comp. Neurol. 397, 139147.
  • Bayer T. A., Wirths O., Majtenyi K., Hartmann T., Multhaup G., Beyreuther K. and Czech C. (2001) Key factors in Alzheimer's disease: beta-amyloid precursor protein processing, metabolism and intraneuronal transport. Brain Pathol. 11, 111.
  • Benito A., Lerga A., Silva M., Leon J. and Fernandez-Luna J. L. (1997) Apoptosis of human myeloid leukemia cells induced by an inhibitor of protein phosphatases (okadaic acid) is prevented by Bcl-2 and Bcl-X(L). Leukemia 11, 940944.
  • Blanchard V., Moussaoui S., Czech C. et al. (2003) Time sequence of maturation of dystrophic neurites associated with Abeta deposits in APP/PS1 transgenic mice. Exp. Neurol. 184, 247263.
  • Braak H. and Braak E. (1991) Neuropathological staging of Alzheimer-related changes. Acta Neuropathol. (Berl.) 82, 239259.
  • Burdick D., Kosmoski J., Knauer M. F. and Glabe C. G. (1997) Preferential adsorption, internalization and resistance to degradation of the major isoform of the Alzheimer's amyloid peptide, A beta 1–42, in differentiated PC12 cells. Brain Res. 746, 275284.
  • Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H. and Yankner B. A. (2002) Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33, 677688.
  • Chui D. H., Dobo E., Makifuchi T., Akiyama H., Kawakatsu S., Petit A., Checler F., Araki W., Takahashi K. and Tabira T. (2001) Apoptotic neurons in Alzheimer's disease frequently show intracellular Abeta42 labeling. J. Alzheimer's Dis. 3, 231239.
  • Cook D. G., Forman M. S., Sung J. C., Leight S., Kolson D. L., Iwatsubo T., Lee V. M. and Doms R. W. (1997) Alzheimer's Abeta (1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3, 10211023.
  • D'Andrea M. R., Nagele R. G., Wang H. Y., Peterson P. A. and Lee D. H. (2001) Evidence that neurones accumulating amyloid can undergo lysis to form amyloid plaques in Alzheimer's disease. Histopathology 38, 120134.DOI: 10.1046/j.1365-2559.2001.01082.x
  • D'Andrea M. R., Nagele R. G., Wang H. Y. and Lee D. H. (2002) Consistent immunohistochemical detection of intracellular beta-amyloid42 in pyramidal neurons of Alzheimer's disease entorhinal cortex. Neurosci. Lett. 333, 163166.DOI: 10.1016/S0304-3940(02)00875-3
  • D'Andrea M. R., Reiser P. A., Polkovitch D. A., Gumula N. A., Branchide B., Hertzog B. M., Schmidheiser D., Belkowski S., Gastard M. C. and Andrade-Gordon P. (2003) The use of formic acid to embellish amyloid plaque detection in Alzheimer's disease tissues misguides key observations. Neurosci. Lett. 342, 114118.DOI: 10.1016/S0304-3940(03)00252-0
  • Ditaranto K., Tekirian T. L. and Yang A. J. (2001) Lysosomal membrane damage in soluble Abeta-mediated cell death in Alzheimer's disease. Neurobiol. Dis. 8, 1931.DOI: 10.1006/nbdi.2000.0364
  • Enya M., Morishima-Kawashima M., Yoshimura M. et al. (1999) Appearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging. Am. J. Pathol. 154, 271279.
  • Fernandez-Vizarra P., Fernandez A. P., Castro-Blanco S. et al. (2004) Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. Histol. Histopathol. 19, 823844.
  • Glenner G. G. and Wong C. W. (1984) Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Gong Y., Chang L., Viola K. L., Lacor P. N., Lambert M. P., Finch C. E., Krafft G. A. and Klein W. L. (2003) Alzheimer's disease-affected brain: presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl Acad. Sci. USA 100, 10 41710 422.
  • Gouras G. K., Tsai J., Naslund J. et al. (2000) Intraneuronal Abeta42 accumulation in human brain. Am. J. Pathol. 156, 1520.
  • Greenfield J. P., Tsai J., Gouras G. K., Hai B., Thinakaran G., Checler F., Sisodia S. S., Greengard P. and Xu H. (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc. Natl Acad. Sci. USA 96, 742747.
  • Grimm H. S., Beher D., Lichtenthaler S. F., Shearman M. S., Beyreuther K. and Hartmann T. (2003) gamma-Secretase cleavage site specificity differs for intracellular and secretory amyloid beta. J. Biol. Chem. 278, 13 07713 085.
  • Grimm M. O., Tomic I. and Hartmann T. (2002) Potential external source of Abeta in biological samples. Nat. Cell Biol. 4, E164E165.
  • Gyure K. A., Durham R., Stewart W. F., Smialek J. E. and Troncoso J. C. (2001) Intraneuronal abeta-amyloid precedes development of amyloid plaques in Down syndrome. Arch. Pathol. Lab. Med. 125, 489492.
  • Hardy J. and Allsop D. (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol. Sci. 12, 383388.
  • Hartmann T., Bieger S. C., Bruhl B. et al. (1997) Distinct sites of intracellular production for Alzheimer's disease A beta40/42 amyloid peptides. Nat. Med. 3, 10161020.
  • Holcomb L., Gordon M. N., McGowan E. et al. (1998) Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat. Med. 4, 97100.
  • Hsia A. Y., Masliah E., McConlogue L., Yu G. Q., Tatsuno G., Hu K., Kholodenko D., Malenka R. C., Nicoll R. A. and Mucke L. (1999) Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models. Proc. Natl Acad. Sci. USA 96, 32283233.
  • Ida N., Masters C. L. and Beyreuther K. (1996) Rapid cellular uptake of Alzheimer amyloid betaA4 peptide by cultured human neuroblastoma cells. FEBS Lett. 394, 174178.
  • Jellinger K. A. (2001) Cell death mechanisms in neurodegeneration. J. Cell Mol. Med. 5, 117.
  • Kawarabayashi T., Shoji M., Younkin L. H., Wen-Lang L., Dickson D. W., Murakami T., Matsubara E., Abe K., Ashe K. H. and Younkin S. G. (2004) Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease. J. Neurosci. 24, 38013809.
  • Kienlen-Campard P., Miolet S., Tasiaux B. and Octave J. N. (2002) Intracellular amyloid-beta 1–42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis. J. Biol. Chem. 277, 15 66615 670.
  • Knauer M. F., Soreghan B., Burdick D., Kosmoski J. and Glabe C. G. (1992) Intracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein. Proc. Natl Acad. Sci. USA 89, 74377441.
  • LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C. and Jay G. (1995) The Alzheimer's Abeta peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nat. Genet. 9, 2130.
  • LaFerla F. M., Troncoso J. C., Strickland D. K., Kawas C. H. and Jay G. (1997) Neuronal cell death in Alzheimer's disease correlates with apoE uptake and intracellular Abeta stabilization. J. Clin. Invest. 100, 310320.
  • Lambert M. P., Barlow A. K., Chromy B. A. et al. (1998) Diffusible, nonfibrillar ligands derived from Abeta1–42 are potent central nervous system neurotoxins. Proc. Natl Acad. Sci. USA 95, 64486453.
  • Martin B. L., Schrader-Fischer G., Busciglio J., Duke M., Paganetti P. and Yankner B. A. (1995) Intracellular accumulation of beta-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270, 26 72726 730.
  • Masters C. L., Multhaup G., Simms G., Pottgiesser J., Martins R. N. and Beyreuther K. (1985) Neuronal origin of a cerebral amyloid: neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels. EMBO J. 11, 27572763.
  • Misonou H., Morishima-Kawashima M. and Ihara Y. (2000) Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells. Biochemistry 39, 69516959.
  • Mochizuki A., Tamaoka A., Shimohata A., Komatsuzaki Y. and Shoji S. (2000) Abeta42-positive non-pyramidal neurons around amyloid plaques in Alzheimer's disease. Lancet 355, 4243.
  • Moechars D., Dewachter I., Lorent K. et al. (1999) Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 64836492.
  • Mori C., Spooner E. T., Wisniewsk K. E., Wisniewski T. M., Yamaguch H., Saido T. C., Tolan D. R., Selkoe D. J. and Lemere C. A. (2002) Intraneuronal Abeta42 accumulation in Down syndrome brain. Amyloid 9, 88102.
  • Morrison J. H. and Hof P. R. (1997) Life and death of neurons in the aging brain. Science 278, 412419.
  • Nagy Z., Hindley N. J., Braak H., Braak E., Yilmazer-Hanke D. M., Schultz C., Barnetson L., Jobst K. A. and Smith A. D. (1999) Relationship between clinical and radiological diagnostic criteria for Alzheimer's disease and the extent of neuropathology as reflected by ‘stages’: a prospective study. Dement. Geriatr. Cogn. Disord. 10, 109114.
  • Nunomura A., Perry G., Aliev G. et al. (2001) Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 759767.
  • Nyabi O., Pype S., Mercken M., Herreman A., Saftig P., Craessaerts K., Serneels L., Annaert W. and De Strooper B. (2002) No endogenous A beta production in presenilin-deficient fibroblasts. Nat. Cell Biol. 4, E164.
  • Oddo S., Caccamo A., Shepherd J. D., Murphy M. P., Golde T. E., Kayed R., Metherate R., Mattson M. P., Akbari Y. and LaFerla F. M. (2003) Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409421.
  • Ohyagi Y., Yamada T., Nishioka K., Clarke N. J., Tomlinson A. J., Naylor S., Nakabeppu Y., Kira J. and Younkin S. G. (2000) Selective increase in cellular Abeta 42 is related to apoptosis but not necrosis. Neuroreport 11, 167171.
  • Paola D., Domenicotti C., Nitti M. et al. (2000) Oxidative stress induces increase in intracellular amyloid beta-protein production and selective activation of betaI and betaII PKCs in NT2 cells. Biochem. Biophys. Res. Commun. 268, 642646.
  • Park H. J., Seong Y. M., Choi J. Y., Kang S. and Rhim H. (2004) Alzheimer's disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neurosci. Lett. 357, 6367.
  • Qi Y., Morishima-Kawashima M., Sato T., Mitsumori R. and Ihara Y. (2003) Distinct mechanisms by mutant presenilin 1 and 2 leading to increased intracellular levels of amyloid beta-protein 42 in Chinese hamster ovary cells. Biochemistry 42, 10421052.
  • Schmechel A., Zentgraf H., Scheuermann S., Fritz G., Pipkorn R., Reed J., Beyreuther K., Bayer T. A. and Multhaup G. (2003) Alzheimer beta-amyloid homodimers facilitate A beta fibrillization and the generation of conformational antibodies. J. Biol. Chem. 278, 35 31735 324.
  • Schmitz C., Rutten B. P., Pielen A. et al. (2004) Hippocampal neuron loss exceeds amyloid plaque load in a transgenic mouse model of Alzheimer's disease. Am. J. Pathol. 164, 14951502.
  • Schwab C. and McGeer P. L. (2000) Abeta42-carboxy-terminal-like immunoreactivity is associated with intracellular neurofibrillary tangles and pick bodies. Exp. Neurol. 161, 527534.
  • Sheng J. G., Bora S. H., Xu G., Borchelt D. R., Price D. L. and Koliatsos V. E. (2003) Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis. 14, 133145.
  • Shie F. S., LeBoeur R. C. and Jin L. W. (2003) Early intraneuronal Abeta deposition in the hippocampus of APP transgenic mice. Neuroreport 14, 123129.
  • Skovronsky D. M., Doms R. W. and Lee V. M. (1998) Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture. J. Cell Biol. 141, 10311039.
  • Sudoh S., Kawamura Y., Sato S., Wang R., Saido T. C., Oyama F., Sakaki Y., Komano H. and Yanagisawa K. (1998) Presenilin 1 mutations linked to familial Alzheimer's disease increase the intracellular levels of amyloid beta-protein 1–42 and its N-terminally truncated variant(s) which are generated at distinct sites. J. Neurochem. 71, 15351543.
  • Sun X., Cole G. M., Chu T., Xia W., Galasko D., Yamaguchi H., Tanemura K., Frautschy S. A. and Takashima A. (2002) Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiol. Aging 23, 195203.
  • Suzuki N., Cheung T. T., Cai X. D., Odaka A., Otvos L. Jr, Eckman C., Golde T. E. and Younkin S. G. (1994) An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants. Science 264, 13361340.
  • Takahashi R. H., Milner T. A., Li F., Nam E. E., Edgar M. A., Yamaguchi H., Beal M. F., Xu H., Greengard P. and Gouras G. K. (2002) Intraneuronal Alzheimer abeta42 accumulates in multivesicular bodies and is associated with synaptic pathology. Am. J. Pathol. 161, 18691879.
  • Takahashi R. H., Almeida C. G., Kearney P. F., Yu F., Lin M. T., Milner T. A. and Gouras G. K. (2004) Oligomerization of Alzheimer's beta-amyloid within processes and synapses of cultured neurons and brain. J. Neurosci. 24, 35923599.
  • Takeda K., Araki W. and Tabira T. (2004) Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur. J. Neurosci. 19, 258264.
  • Turner R. S., Suzuki N., Chyung A. S., Younkin S. G. and Lee V. M. (1996) Amyloids beta40 and beta42 are generated intracellularly in cultured human neurons and their secretion increases with maturation. J. Biol. Chem. 271, 89668970.
  • Walsh D. M., Tseng B. P., Rydel R. E., Podlisny M. B. and Selkoe D. J. (2000) The oligomerization of amyloid beta-protein begins intracellularly in cells derived from human brain. Biochemistry 39, 10 83110 839.
  • Walsh D. M., Klyubin I., Fadeeva J. V., Rowan M. J. and Selkoe D. J. (2002a) Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30, 552557.
  • Walsh D. M., Klyubin I., Fadeeva J. V., Cullen W. K., Anwyl R., Wolfe M. S., Rowan M. J. and Selkoe D. J. (2002b) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535539.
  • Wertkin A. M., Turner R. S., Pleasure S. J., Golde T. E., Younkin S. G., Trojanowski J. Q. and Lee V. M. (1993) Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. Proc. Natl Acad. Sci. USA 90, 95139517.
  • Wild-Bode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y. and Haass C. (1997) Intracellular generation and accumulation of amyloid beta-peptide terminating at amino acid 42. J. Biol. Chem. 272, 16 08516 088.
  • Wilson C. A., Doms R. W., Zheng H. and Lee V. M. (2002) Presenilins are not required for A beta 42 production in the early secretory pathway. Nat. Neurosci. 5, 849855.
  • Wirths O., Multhaup G., Czech C., Blanchard V., Moussaoui S., Tremp G., Pradier L., Beyreuther K. and Bayer T. A. (2001) Intraneuronal Abeta accumulation precedes plaque formation in beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 306, 116120.
  • Wirths O., Multhaup G., Czech C., Feldmann N., Blanchard V., Tremp G., Beyreuther K., Pradier L. and Bayer T. A. (2002) Intraneuronal APP/Abeta trafficking and plaque formation in beta-amyloid precursor protein and presenilin-1 transgenic mice. Brain Pathol. 12, 275286.
  • Xu H., Sweeney D., Wang R., Thinakaran G., Lo A. C., Sisodia S. S., Greengard P. and Gandy S. (1997) Generation of Alzheimer beta-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. Natl Acad. Sci. USA 94, 37483752.
  • Yang A. J., Chandswangbhuvana D., Margol L. and Glabe C. G. (1998) Loss of endosomal/lysosomal membrane impermeability is an early event in amyloid Abeta1–42 pathogenesis. J. Neurosci. Res. 52, 691698.
  • Zhang Y., McLaughlin R., Goodyer C. and LeBlanc A. (2002) Selective cytotoxicity of intracellular amyloid beta peptide1–42 through p53 and Bax in cultured primary human neurons. J. Cell Biol. 156, 519529.